BioNTech (NASDAQ:BNTX) reported quarterly earnings of $1.08 per share which beat the analyst consensus estimate of $0.38 by 184.21 percent. This is a 42.55 percent decrease over earnings of $1.88 per share from the same period last year. The company reported quarterly sales of $1.19 billion which beat the analyst consensus estimate of $1.09 billion by 9.04 percent. This is a 19.54 percent decrease over sales of $1.48 billion the same period last year.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。